Teleflex Incorporated Revenue Growth Rates (TFX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Teleflex Incorporated  (NYSE: TFX)
 

TFX's Revenue Growth by Quarter and Year

Teleflex Incorporated's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TFX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 570.33
1st Quarter March 547.43
FY 1,117.76

TFXs Annual Revenue
Teleflex Incorporated's Revenue in the fiscal year 2025 $ 1,991.75 millions
Teleflex Incorporated's Revenue in the fiscal year 2024 $ 3,046.68 millions
Teleflex Incorporated's Revenue in the fiscal year 2023 $ 2,973.93 millions
Teleflex Incorporated's Revenue in the fiscal year 2022 $ 2,791.04 millions
Teleflex Incorporated's Revenue in the fiscal year 2021 $ 2,809.56 millions




TFX Revenue second quarter 2026 Y/Y Growth Comment
Teleflex Incorporated reported fall in Revenue in the second quarter 2026 by -26.89% to $ 570.33 millions, from the same quarter in 2025.
This represents worst decline in recent Company history.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 173 other companies have achieved higher Revenue growth. While Teleflex Incorporated' s Revenue drop of -26.89% ranks overall at the positon no. 3607 in the second quarter 2026.


TFX Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - - 2.85 % 2.09 %
3rd Quarter September - 19.43 % 2.39 % 8.67 %
2nd Quarter June -26.89 % 4.09 % 0.89 % 5.43 %
1st Quarter March -21.84 % -4.98 % 3.69 % 10.79 %
FY   - -34.64 % 2.45 % -

Financial Statements
Teleflex Incorporated's second quarter 2026 Revenue $ 570.33 millions TFX's Income Statement
Teleflex Incorporated's second quarter 2025 Revenue $ 780.09 millions Quarterly TFX's Income Statement


TFX Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - - 4.15 % 3.69 %
3rd Quarter September - 16.99 % 1.96 % 0.47 %
2nd Quarter June 4.18 % 11.37 % 1.67 % 4.49 %
1st Quarter March - -12 % -4.75 % -6.21 %
FY (Year on Year)   - -34.64 % 2.45 % -


Back to TFX Growth rate Comparisons >> Back to TFX Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #174
Healthcare Sector #497
Overall #3607

Revenue Y/Y Growth Statistics
High Average Low
25.83 % 3.99 % -26.89 %
(Jul 01 2018)   (Jun 30 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #174
Healthcare Sector #497
Overall #3607
Revenue Y/Y Growth Statistics
High Average Low
25.83 % 3.99 % -26.89 %
(Jul 01 2018)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Teleflex Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
16.99 % 1.89 % -15.78 %
(Sep 28 2025)  


TFX's II. Quarter Q/Q Revenue Comment
Teleflex Incorporated achieved in the II. Quarter 2026 above company average sequential Revenue growth of 4.18%, to $ 570.33 millions, from $547.43 millions in the first quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Teleflex Incorporated's Revenue growth quarter on quarter, overall rank is 1214.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #177
Overall #1214
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #177
Overall #1214
Revenue Q/Q Growth Statistics
High Average Low
16.99 % 1.89 % -15.78 %
(Sep 28 2025)  


TFX's II. Quarter Q/Q Revenue Comment
Teleflex Incorporated achieved in the II. Quarter 2026 above company average sequential Revenue growth of 4.18%, to $ 570.33 millions, from $547.43 millions in the first quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Teleflex Incorporated's Revenue growth quarter on quarter, overall rank is 1214.


Teleflex Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 28 2025)		 12 Months Ending
(Jun 29 2025)
Cumulative Revenue 12 Months Ending $ 1,628.53 $ 1,838.29 $ 1,991.30 $ 3,189.08 $ 3,040.61
Y / Y Revenue Growth (TTM) -46.44 % -38.93 % -34.64 % 5.44 % 1.13 %
Year on Year Revenue Growth Overall Ranking # 2496 # 2465 # 1982 # 1965 # 500
Seqeuential Revenue Change (TTM) -11.41 % -7.68 % -37.56 % 4.88 % 1.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 2513 # 2571 # 2146 # 2125 # 2038


Cumulative Revenue growth Comment
Teleflex Incorporated's cumulative 12 months Revenue continue to drop, but on the faster rate at -46.44% year on year, at Jun 30 2026 compare to the -38.93% decrease at Mar 31 2026. If the Teleflex Incorporated's fiscal year would end at Jun 30 2026, annual Revenue would be $1,629 millions.

In the Healthcare sector 364 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2465 to 2496.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 134
Healthcare Sector # 365
Overall # 2496

Revenue TTM Y/Y Growth Statistics
High Average Low
17.16 %
 3.04 %
-46.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 134
Sector # 366
S&P 500 # 2513
Cumulative Revenue growth Comment
Teleflex Incorporated's cumulative 12 months Revenue continue to drop, but on the faster rate at -46.44% year on year, at Jun 30 2026 compare to the -38.93% decrease at Mar 31 2026. If the Teleflex Incorporated's fiscal year would end at Jun 30 2026, annual Revenue would be $1,629 millions.

In the Healthcare sector 364 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2465 to 2496.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 134
Healthcare Sector # 365
Overall # 2496

Revenue TTM Y/Y Growth Statistics
High Average Low
17.16 %
3.04 %
-46.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 134
Sector # 366
S&P 500 # 2513




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TFX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Teleflex Incorporated Revenue Growth Rates (TFX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Teleflex Inc (CIK 96943).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000096943-26-000095
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Teleflex Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.